MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$343M
Net Income
$122M
Net Profit Margin
35.57%
EPS
$0.98
Unit: Million (M) dollars
Revenue Breakdown
Sublocade
Sublingual And Other
Non Us
Perseris
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
343
317
357
314
Cost of sales
50
40
67
83
Gross profit
294
277
293
230
Selling, general and administrative
122
124
189
155
Research and development
12
16
21
33
Acquired in-process research and development
-
-
0*
0
Litigation settlement
-
-
-2
0
Other operating (income) expense, net
-
-
0*
-1
Total operating expenses
134
139
-
187
Operating income
160
137
81
43
Interest (income)
3
3
6
6
Interest expense
2
7
6
12
Loss on debt extinguishment
0
-18
-
-
Income before income taxes
160
115
81
37
Income tax expense
38
26
-21
-5
Net income
122
89
103
42
Basic EPS
1.02
0.71
0.786
0.34
Diluted EPS
0.98
0.69
0.75
0.33
Basic Average Shares
119,000,000
124,000,000
126,000,000
125,000,000
Diluted Average Shares
124,000,000
129,000,000
132,000,000
129,000,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Sublocade
$238M
(22.05%↑ Y/Y)
Sublingual And Other
$57M
(9.62%↑ Y/Y)
Perseris
$5M
(-37.50%↓ Y/Y)
US
$300M
(17.19%↑ Y/Y)
Non Us
$43M
(-6.52%↓ Y/Y)
Net revenue
$343M
(13.58%↑ Y/Y)
Gross profit
$294M
(17.60%↑ Y/Y)
Cost of sales
$50M
(-3.85%↓ Y/Y)
Operating income
$160M
(122.22%↑ Y/Y)
Interest (income)
$3M
(-50.00%↓ Y/Y)
Total operating
expenses
$134M
Income before income
taxes
$160M
(158.06%↑ Y/Y)
Interest expense
$2M
(-86.67%↓ Y/Y)
Selling, general and
administrative
$122M
(-22.78%↓ Y/Y)
Research and development
$12M
(-42.86%↓ Y/Y)
Net income
$122M
(577.78%↑ Y/Y)
Income tax expense
$38M
(-13.64%↓ Y/Y)
Buy us a coffee
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)